Evidence map›Paper›PMID 35028297›Full record

ArticleSchizophrenia research. Cognition2022

Latent inhibition, aberrant salience, and schizotypy traits in cannabis users.

Christopher Dawes, Declan Quinn, Andrea Bickerdike, Cian O'Neill, Kiri T Granger, Sarah Carneiro Pereira, Sue Lynn Mah, Mark Haselgrove, John L Waddington, Colm O'Tuathaigh and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia research. Cognition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Latent Inhibition in Schizophrenia and Schizotypy.Schizophrenia bulletin open · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Christopher DawesSchool of Psychology, University of Nottingham, NG7 2RD, UK.
Declan QuinnSchool of Applied Psychology, University College Cork, Cork, Ireland.
Andrea BickerdikeDepartment of Sport, Leisure, and Childhood Studies, Munster Technological University, Bishopstown, Cork, Ireland.
Cian O'NeillDepartment of Sport, Leisure, and Childhood Studies, Munster Technological University, Bishopstown, Cork, Ireland.
Kiri T GrangerSchool of Psychology, University of Nottingham, NG7 2RD, UK.
Sarah Carneiro PereiraPsychological Sciences Research Institute, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Sue Lynn MahSchool of Psychology, University of Nottingham, NG7 2RD, UK.
Mark HaselgroveSchool of Psychology, University of Nottingham, NG7 2RD, UK.
John L WaddingtonSchool of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Ireland.
Colm O'TuathaighMedical Education Unit, School of Medicine, University College Cork, Cork, Ireland.
Paula M MoranSchool of Psychology, University of Nottingham, NG7 2RD, UK.
University of Nottingham · GBMunster Technological University · IEUniversity College Cork · IERoyal College of Surgeons in Ireland · IEUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant salience processing may underlie the link between cannabis and psychosis, as posited in individuals with schizophrenia or high schizotypy. We investigated the relative effects of cannabis use, schizotypy status, and self-reported aberrant salience experiences on salience processing, measured using a latent inhibition (LI) task (Granger et al., 2016), in a non-clinical population. A university sample of 346 participants completed the Schizotypal Personality Questionnaire (SPQ), Aberrant Salience Inventory (ASI) the modified Cannabis Experience Questionnaire (CEQmv) and the LI task. Regression models and parallel (Bayesian and frequentist)

Indexed as

Aberrant salienceCannabisLatent inhibitionPsychosisSchizotypy

Identifiers

PMID35028297
PMCPMC8738960
OpenAlexW4206843342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.